An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase

Gene expression profiling has the potential to enhance current methods for the diagnosis of haematological malignancies. Here, we present data on 204 analyses from an international standardization programme that was conducted in 11 laboratories as a prephase to the Microarray Innovations in LEukemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohlmann, Alexander, Kipps, Thomas J, Rassenti, Laura Z, Downing, James R, Shurtleff, Sheila A, Mills, Ken I, Gilkes, Amanda F, Hofmann, Wolf-Karsten, Basso, Giuseppe, Dell’Orto, Marta Campo, Foà, Robin, Chiaretti, Sabina, De Vos, John, Rauhut, Sonja, Papenhausen, Peter R, Hernández, Jesus M, Lumbreras, Eva, Yeoh, Allen E, Koay, Evelyn S, Li, Rachel, Liu, Wei-min, Williams, Paul M, Wieczorek, Lothar, Haferlach, Torsten
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654477/
https://www.ncbi.nlm.nih.gov/pubmed/18573112
http://dx.doi.org/10.1111/j.1365-2141.2008.07261.x
Descripción
Sumario:Gene expression profiling has the potential to enhance current methods for the diagnosis of haematological malignancies. Here, we present data on 204 analyses from an international standardization programme that was conducted in 11 laboratories as a prephase to the Microarray Innovations in LEukemia (MILE) study. Each laboratory prepared two cell line samples, together with three replicate leukaemia patient lysates in two distinct stages: (i) a 5-d course of protocol training, and (ii) independent proficiency testing. Unsupervised, supervised, and r(2) correlation analyses demonstrated that microarray analysis can be performed with remarkably high intra-laboratory reproducibility and with comparable quality and reliability.

Ejemplares similares